Ítem
Solo Metadatos
Toxoplasma gondii: Immunogenicity and protection by P30 peptides in a murine model
| dc.creator | Siachoque H. | spa |
| dc.creator | Guzman F. | spa |
| dc.creator | Burgos J. | spa |
| dc.creator | Patarroyo M.E. | spa |
| dc.creator | Gomez Marin J.E. | spa |
| dc.date.accessioned | 2020-05-26T00:07:52Z | |
| dc.date.available | 2020-05-26T00:07:52Z | |
| dc.date.created | 2006 | spa |
| dc.description.abstract | Vaccines are promising for the control of toxoplasmosis. Here, we evaluated the immunogenicity of 17 peptides derived from SAG1 surface protein of Toxoplasma gondii in CH3 mice. Only 8 of 16 peptides induced specific antibodies. After a lethal challenge, only the vaccination with 4 of 17 peptides that were from the carboxy terminal end of the protein conferred significant survival. Our work shows that vaccination with peptides from the carboxy-terminal positions of SAG1 major surface protein of Toxoplasma protects mice against a lethal challenge. © 2006 Elsevier Inc. All rights reserved. | eng |
| dc.format.mimetype | application/pdf | |
| dc.identifier.doi | https://doi.org/10.1016/j.exppara.2006.02.005 | |
| dc.identifier.issn | 00144894 | |
| dc.identifier.issn | 10902449 | |
| dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/24037 | |
| dc.language.iso | eng | spa |
| dc.relation.citationEndPage | 65 | |
| dc.relation.citationIssue | No. 1 | |
| dc.relation.citationStartPage | 62 | |
| dc.relation.citationTitle | Experimental Parasitology | |
| dc.relation.citationVolume | Vol. 114 | |
| dc.relation.ispartof | Experimental Parasitology, ISSN:00144894, 10902449, Vol.114, No.1 (2006); pp. 62-65 | spa |
| dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746905060&doi=10.1016%2fj.exppara.2006.02.005&partnerID=40&md5=3e0b22c255906acdcaa51e6295815d14 | spa |
| dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
| dc.rights.acceso | Abierto (Texto Completo) | spa |
| dc.source.instname | instname:Universidad del Rosario | spa |
| dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
| dc.subject.keyword | Cysteinylisoleucyllysylglycylaspartylaspartylalanylglutaminylseryl cysteinylmethionylvalylthreonylvalylthreonylvalylglutaminylalanylarginylalanine | spa |
| dc.subject.keyword | animal | eng |
| dc.subject.keyword | Isoleucyllysylleucylthreonylvalylprolylisoleucylglutamyllysylphenylalanyl prolylvalylthreonylthreonylglutaminylthreonylphenylalanylvalylvalylglycine | spa |
| dc.subject.keyword | Isoleucylprolylglutamylalanylglutamylaspartylseryltryptophanyltryptophanyl threonylglycylaspartylserylalanylserylleucylaspartylthreonylalanylglycine | spa |
| dc.subject.keyword | Leucylarginylcysteinylglycylvalylmethionylalanylserylaspartylprolylprolyl leucylvalylalanylasparaginylglutaminylvalylvalylthreonylcysteine | spa |
| dc.subject.keyword | Lysylalanylvalylarginylarginylalanylvalylthreonylalanylglycylvalyl phenylalanylalanylalanylprolylthreonylleucylmethionylserylphenylalanine | spa |
| dc.subject.keyword | Lysylcysteinylprolyllysylthreonylalanylleucylthreonylglutamylprolylprolyl threonylleucylalanyltyrosylserylprolylasparaginylarginylglutamine | spa |
| dc.subject.keyword | Lysylserylphenylalanyllysylaspartylisoleucylleucylprolyllysylleucyl threonylglutamylasparaginylprolyltryptophanylglutaminylglycylasparaginylalanyl serine | spa |
| dc.subject.keyword | Lysylvalylprolylglutaminylaspartylasparaginylasparaginylglutaminyltyrosyl cysteinylserylglycylthreonylthreonylleucylthreonylglycylcysteinylasparaginyl glutamic acid | spa |
| dc.subject.keyword | Membrane protein | spa |
| dc.subject.keyword | Methionylserylvalylserylleucylhistidylhistidylphenylalanylisoleucyl isoleucylserylserylglycylphenylalanylleucylthreonylserylmethionylphenylalanyl proline | spa |
| dc.subject.keyword | Peptide derivative | spa |
| dc.subject.keyword | Phenylalanylalanylglycylalanylalanylglycylserylalanyllysylserylalanyl alanylglycylthreonylalanylserylhistidylvalylserylisoleucine | spa |
| dc.subject.keyword | Phenylalanylalanylmethionylvalylisoleucylglycylleucylisoleucylglycylseryl isoleucylalanylalanylcysteinylvalylalanine | spa |
| dc.subject.keyword | Prolylaspartyllysyllysylserylthreonylalanylalanylvalylisoleucylleucyl threonylprolylthreonylglutamylasparaginylhistidylphenylalanylthreonylleucine | spa |
| dc.subject.keyword | Protein sag1 | spa |
| dc.subject.keyword | Serylaspartyllysylglycylalanylthreonylleucylthreonylisoleucyllysyllysyl glutamylalanylphenylalanylprolylalanylglutamylseryllysylserine | spa |
| dc.subject.keyword | Serylserylvalylvalylasparaginylasparaginylalanylarginylcysteinylseryl tyrosylglycylalanylaspartylserylthreonylleucylglycylproline | spa |
| dc.subject.keyword | Unclassified drug | spa |
| dc.subject.keyword | Valylisoleucylisoleucylglycylcysteinylthreonylglycylglycylserylprolyl glutamyllysylhistidylhistidylcysteinylthreonylvalyllysylleucylglutamic acid | spa |
| dc.subject.keyword | Valyllysylleucylserylalanylglutamylglycylprolylthreonylthreonylmethionyl threonylleucylvalylcysteinylglycyllysylaspartylglycylvaline | spa |
| dc.subject.keyword | Animal experiment | spa |
| dc.subject.keyword | Animal model | spa |
| dc.subject.keyword | Article | spa |
| dc.subject.keyword | Carboxy terminal sequence | spa |
| dc.subject.keyword | Controlled study | spa |
| dc.subject.keyword | Immunogenicity | spa |
| dc.subject.keyword | Male | spa |
| dc.subject.keyword | Mouse | spa |
| dc.subject.keyword | Nonhuman | spa |
| dc.subject.keyword | Nucleotide sequence | spa |
| dc.subject.keyword | Priority journal | spa |
| dc.subject.keyword | Survival | spa |
| dc.subject.keyword | Toxoplasma gondii | spa |
| dc.subject.keyword | Toxoplasmosis | spa |
| dc.subject.keyword | Vaccination | spa |
| dc.subject.keyword | Amino acid sequence | spa |
| dc.subject.keyword | Animals | spa |
| dc.subject.keyword | Antibodies | eng |
| dc.subject.keyword | Antigens | eng |
| dc.subject.keyword | Antigens | eng |
| dc.subject.keyword | Immunization | eng |
| dc.subject.keyword | Male | spa |
| dc.subject.keyword | Mice | spa |
| dc.subject.keyword | Mice | eng |
| dc.subject.keyword | Molecular sequence data | spa |
| dc.subject.keyword | Peptides | spa |
| dc.subject.keyword | Protozoan proteins | spa |
| dc.subject.keyword | Protozoan vaccines | spa |
| dc.subject.keyword | Toxoplasma | spa |
| dc.subject.keyword | Toxoplasmosis | eng |
| dc.subject.keyword | Murinae | spa |
| dc.subject.keyword | Toxoplasma | spa |
| dc.subject.keyword | Toxoplasma gondii | spa |
| dc.subject.keyword | Murine model | spa |
| dc.subject.keyword | P30 | spa |
| dc.subject.keyword | Peptides | spa |
| dc.subject.keyword | Sag1 | spa |
| dc.subject.keyword | Toxoplasma gondii | spa |
| dc.subject.keyword | Vaccines | spa |
| dc.title | Toxoplasma gondii: Immunogenicity and protection by P30 peptides in a murine model | spa |
| dc.type | article | eng |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
| dc.type.spa | Artículo | spa |



